S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin

Arthritis and Rheumatism

Volumn 58, Issue 12, 2008, Pages 3924-3931

  Wittkowski, Helmut ^a   Frosch, Michael ^a   Wulffraat, Nico ^b   Goldbach Mansky, Raphaela ^c   Kallinich, Tilmann ^d   Kuemmerle Deschner, Jasmin ^e   Frühwald, Michael C ^a   Dassmann, Sandra ^a   Pham, Tuyet Hang ^c   Roth, Johannes ^a,f   Foell, Dirk ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^f UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; MOLECULAR MARKER; S100A12 PROTEIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CELL ACTIVATION; CINCA SYNDROME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MUCKLE WELLS SYNDROME; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PYREXIA IDIOPATHICA; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FEVER OF UNKNOWN ORIGIN; GRANULOCYTES; HUMANS; INFANT; INFECTION; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 57349086217     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24137     Document Type: Article

References (39)

1. Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore) 1961;40:1-30.
2. Durack DT, Street AC. Fever of unknown origin: reexamined and redefined [review]. Curr Clin Top Infect Dis 1991;11:35-51.
3. Arnow PM, Flaherty JP. Fever of unknown origin [review]. Lancet 1997;350:575-80.
4. Gaeta GB, Fusco FM, Nardiello S. Fever of unknown origin: a systematic review of the literature for 1995-2004 [review]. Nucl Med Commun 2006;27:205-11.
5. Woo P, Wedderburn LR. Juvenile chronic arthritis [review]. Lancet 1998;351:969-73.
6. Schneider R, Laxer RM. Systemic onset juvenile rheumatoid arthritis [review]. Baillieres Clin Rheumatol 1998;12:245-71.
7. Woo P. Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome [review]. Nat Clin Pract Rheumatol 2006;2:28-34.
8. Jarvis JN. Pathogenesis and mechanisms of inflammation in the childhood rheumatic diseases [review]. Curr Opin Rheumatol 1998;10:459-67.
9. Niki Y, Yamada H, Seki S, Kikuchi T, Takaishi H, Toyama Y, et al. Macrophage- and neutrophil-dominant arthritis in human IL-1α transgenic mice. J Clin Invest 2001;107:1127-35.
10. Muller K, Herner EB, Stagg A, Bendtzen K, Woo P. Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritis. Br J Rheumatol 1998;37:562-9.
11. Foell D, Wittkowski H, Hammerschmidt I, Wulffraat NM, Schmeling H, Frosch M, et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum 2004;50:1286-95.
12. Foell D, Wittkowski H, Roth J. Mechanisms of disease: a 'DAMP' view of inflammatory arthritis [review]. Nat Clin Pract Rheumatol 2007;3:382-90.
13. Wittkowski H, Sturrock A, van Zoelen MA, Viemann D, van der Poll T, Hoidal JR, et al. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit Care Med 2007;35:1369-75.
14. Xie J, Burz DS, He W, Bronstein IB, Lednev I, Shekhtman A. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J Biol Chem 2007;282:4218-31.
15. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97:889-901.
16. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001;108:949-55.
17. Foell D, Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease [review]. Arthritis Rheum 2004;50:3762-71.
18. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
19. Ruperto N, Ravelli A, Falcini F, Lepore L, De Sanctis R, Zulian F, et al, for the Italian Pediatric Rheumatology Study Group. Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Ann Rheum Dis 1998;57:38-41.
20. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
21. Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, et al. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003;52:847-53.
22. Vogl T, Propper C, Hartmann M, Strey A, Strupat K, van den Bos C, et al. S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14. J Biol Chem 1999;274:25291-6.
23. Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, et al. Fecal S100A12 as non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 2007;56:1706-13.
24. Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition. N Engl J Med 2006;355:581-92.
25. American College of Rheumatology Ad Hoc Committee on Immunologic Testing. Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction. Arthritis Rheum 2002;47:429-33.
26. Federici L, Rittore-Domingo C, Kone-Paut I, Jorgensen C, Rodiere M, Le Quellec A, et al. A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients. Ann Rheum Dis 2006;65:1427-32.
27. Drenth JP, van der Meer JW. Hereditary periodic fever [review]. N Engl J Med 2001;345:1748-57.
28. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005;201:1479-86.
29. Fitzgerald AA, LeClercq SA, Yan A, Homik JE, Dinarello CA. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 2005;52:1794-803.
30. Dinarello CA. Blocking IL-1 in systemic inflammation [review]. J Exp Med 2005;201:1355-9.
31. Lequerre T, Quartier P, Rosellini D, Alaoui F, De Bandt M, Mejjad O, et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 2008;67:302-8.
32. Yang Z, Tao T, Raftery MJ, Youssef P, Di Girolamo N, Geczy CL. Proinflammatory properties of the human S100 protein S100A12. J Leukoc Biol 2001;69:986-94.
33. Foell D, Ichida F, Vogl T, Yu X, Chen R, Miyawaki T, et al. S100A12 (EN-RAGE) in monitoring Kawasaki disease. Lancet 2003;361:1270-2.
34. Foell D, Kane D, Bresnihan B, Vogl T, Nacken W, Sorg C, et al. Expression of the pro-inflammatory protein S100A12 (ENRAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford) 2003;42:1383-9.
35. Foell D, Hernandez-Rodriguez J, Sanchez M, Vogl T, Cid MC, Roth J. Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis. J Pathol 2004;204:311-6.
36. Wittkowski H, Foell D, af Klint E, De Rycke L, De Keyser F, Frosch M, et al. Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis. Ann Rheum Dis 2007;66:1020-5.
37. Sobieska M, Fassbender K, Aeschlimann A, Bourgeois P, Mackiewicz S, Muller W. Still's disease in children and adults: a distinct pattern of acute-phase proteins. Clin Rheumatol 1998;17:258-60.
38. Ogilvie EM, Khan A, Hubank M, Kellam P, Woo P. Specific gene expression profiles in systemic juvenile idiopathic arthritis. Arthritis Rheum 2007;56:1954-65.
39. Allantaz F, Chaussabel D, Stichweh D, Bennett L, Allman W, Mejias A, et al. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J Exp Med 2007;204:2131-44.